Application of E-health and Machine Learning in the Post-COVID-19 Era
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 455
Special Issue Editor
Special Issue Information
Dear Colleagues,
Learning is an important intelligent behavior of human beings, and the current development of artificial intelligence also enables the computer to have the ability of "learning". Machine learning refers to "the behavior of the computer to automatically improve the performance of the system by using experience". With the overall development of medical big data and "artificial intelligence + medical", the application of machine learning in public health is becoming more and more extensive. Breakthroughs have been made in medical imaging, clinical decision support, speech recognition, drug mining, health management, pathology, and many other fields, which is of great help to improve the accuracy, safety, and reliability of medical system diagnosis.
We would be delighted to invite you to submit your original manuscripts, comments, position papers, and case studies on the concepts, developments, applicability, and applications of machine learning in the post-COVID-19 era in medicine and public health. It will also consider communications relating to lessons learned from the past and current health crises related to future pandemic preparedness.
Dr. Luigia Brugliera
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- post-COVID-19
- medicine
- public health
- machine learning
- drug mining
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
